adesso SE
adesso SE (ADN1.DE) Stock Competitors & Peer Comparison
See (ADN1.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Information Technology Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ADN1.DE | €80.30 | +4.15% | 515.9M | -730.00 | -€0.11 | +0.93% |
| IBM.DE | €216.05 | +0.02% | 201.3B | 39.79 | €5.43 | +2.91% |
| FIV.DE | €219.40 | +0.27% | 126.3B | 62.87 | €3.49 | N/A |
| COZ.DE | €84.46 | -0.68% | 41.6B | 19.78 | €4.27 | +1.33% |
| BC8.DE | €34.98 | +0.52% | 4.4B | 19.43 | €1.80 | +2.00% |
| 4018.F | €1,245.00 | -0.40% | 1.9B | 72.59 | €17.15 | N/A |
| 217A.F | €6.70 | -0.74% | 1.8B | -675.00 | -€0.01 | N/A |
| NB2.F | €21.30 | +2.31% | 1.4B | -9.52 | -€2.21 | N/A |
| NB2.DE | €20.92 | +0.00% | 1.3B | -9.47 | -€2.21 | N/A |
| CHG.DE | €43.20 | -0.92% | 1B | -86.40 | -€0.50 | N/A |
Stock Comparison
ADN1.DE vs IBM.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, IBM.DE has a market cap of 201.3B. Regarding current trading prices, ADN1.DE is priced at €80.30, while IBM.DE trades at €216.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas IBM.DE's P/E ratio is 39.79. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to IBM.DE's ROE of +0.22%. Regarding short-term risk, ADN1.DE is more volatile compared to IBM.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check IBM.DE's competition here
ADN1.DE vs FIV.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, FIV.DE has a market cap of 126.3B. Regarding current trading prices, ADN1.DE is priced at €80.30, while FIV.DE trades at €219.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas FIV.DE's P/E ratio is 62.87. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to FIV.DE's ROE of +0.11%. Regarding short-term risk, ADN1.DE is more volatile compared to FIV.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check FIV.DE's competition here
ADN1.DE vs COZ.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, COZ.DE has a market cap of 41.6B. Regarding current trading prices, ADN1.DE is priced at €80.30, while COZ.DE trades at €84.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas COZ.DE's P/E ratio is 19.78. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to COZ.DE's ROE of +0.16%. Regarding short-term risk, ADN1.DE is more volatile compared to COZ.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check COZ.DE's competition here
ADN1.DE vs BC8.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, BC8.DE has a market cap of 4.4B. Regarding current trading prices, ADN1.DE is priced at €80.30, while BC8.DE trades at €34.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas BC8.DE's P/E ratio is 19.43. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to BC8.DE's ROE of +0.12%. Regarding short-term risk, ADN1.DE is more volatile compared to BC8.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check BC8.DE's competition here
ADN1.DE vs 4018.F Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, 4018.F has a market cap of 1.9B. Regarding current trading prices, ADN1.DE is priced at €80.30, while 4018.F trades at €1,245.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas 4018.F's P/E ratio is 72.59. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to 4018.F's ROE of +0.04%. Regarding short-term risk, ADN1.DE is more volatile compared to 4018.F. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check 4018.F's competition here
ADN1.DE vs 217A.F Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, 217A.F has a market cap of 1.8B. Regarding current trading prices, ADN1.DE is priced at €80.30, while 217A.F trades at €6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas 217A.F's P/E ratio is -675.00. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to 217A.F's ROE of +0.02%. Regarding short-term risk, ADN1.DE is more volatile compared to 217A.F. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check 217A.F's competition here
ADN1.DE vs NB2.F Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, NB2.F has a market cap of 1.4B. Regarding current trading prices, ADN1.DE is priced at €80.30, while NB2.F trades at €21.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas NB2.F's P/E ratio is -9.52. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to NB2.F's ROE of -0.16%. Regarding short-term risk, ADN1.DE is more volatile compared to NB2.F. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check NB2.F's competition here
ADN1.DE vs NB2.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, NB2.DE has a market cap of 1.3B. Regarding current trading prices, ADN1.DE is priced at €80.30, while NB2.DE trades at €20.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas NB2.DE's P/E ratio is -9.47. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to NB2.DE's ROE of -0.16%. Regarding short-term risk, ADN1.DE is more volatile compared to NB2.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check NB2.DE's competition here
ADN1.DE vs CHG.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, CHG.DE has a market cap of 1B. Regarding current trading prices, ADN1.DE is priced at €80.30, while CHG.DE trades at €43.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas CHG.DE's P/E ratio is -86.40. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to CHG.DE's ROE of -0.03%. Regarding short-term risk, ADN1.DE is more volatile compared to CHG.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check CHG.DE's competition here
ADN1.DE vs DE000A3H2200.SG Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, DE000A3H2200.SG has a market cap of 732.9M. Regarding current trading prices, ADN1.DE is priced at €80.30, while DE000A3H2200.SG trades at €53.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas DE000A3H2200.SG's P/E ratio is N/A. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to DE000A3H2200.SG's ROE of +0.20%. Regarding short-term risk, ADN1.DE is less volatile compared to DE000A3H2200.SG. This indicates potentially lower risk in terms of short-term price fluctuations for ADN1.DE.Check DE000A3H2200.SG's competition here
ADN1.DE vs NA9.F Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, NA9.F has a market cap of 714.5M. Regarding current trading prices, ADN1.DE is priced at €80.30, while NA9.F trades at €53.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas NA9.F's P/E ratio is 16.59. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to NA9.F's ROE of +0.20%. Regarding short-term risk, ADN1.DE is more volatile compared to NA9.F. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check NA9.F's competition here
ADN1.DE vs COK.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, COK.DE has a market cap of 709.1M. Regarding current trading prices, ADN1.DE is priced at €80.30, while COK.DE trades at €22.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas COK.DE's P/E ratio is 28.13. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to COK.DE's ROE of +0.04%. Regarding short-term risk, ADN1.DE is more volatile compared to COK.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check COK.DE's competition here
ADN1.DE vs USY1.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, USY1.DE has a market cap of 700.6M. Regarding current trading prices, ADN1.DE is priced at €80.30, while USY1.DE trades at €10.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas USY1.DE's P/E ratio is -2.10. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to USY1.DE's ROE of +2.03%. Regarding short-term risk, ADN1.DE is more volatile compared to USY1.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check USY1.DE's competition here
ADN1.DE vs NA9.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, NA9.DE has a market cap of 692.9M. Regarding current trading prices, ADN1.DE is priced at €80.30, while NA9.DE trades at €53.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas NA9.DE's P/E ratio is 16.09. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to NA9.DE's ROE of +0.20%. Regarding short-term risk, ADN1.DE is less volatile compared to NA9.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ADN1.DE.Check NA9.DE's competition here
ADN1.DE vs SHF.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, SHF.DE has a market cap of 531.7M. Regarding current trading prices, ADN1.DE is priced at €80.30, while SHF.DE trades at €73.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas SHF.DE's P/E ratio is 25.35. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to SHF.DE's ROE of +0.17%. Regarding short-term risk, ADN1.DE is more volatile compared to SHF.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check SHF.DE's competition here
ADN1.DE vs D6H.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, D6H.DE has a market cap of 498.5M. Regarding current trading prices, ADN1.DE is priced at €80.30, while D6H.DE trades at €60.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas D6H.DE's P/E ratio is 20.07. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to D6H.DE's ROE of +0.16%. Regarding short-term risk, ADN1.DE is more volatile compared to D6H.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check D6H.DE's competition here
ADN1.DE vs GFT.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, GFT.DE has a market cap of 460.2M. Regarding current trading prices, ADN1.DE is priced at €80.30, while GFT.DE trades at €17.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas GFT.DE's P/E ratio is 10.66. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to GFT.DE's ROE of +0.17%. Regarding short-term risk, ADN1.DE is more volatile compared to GFT.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check GFT.DE's competition here
ADN1.DE vs IXX.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, IXX.DE has a market cap of 422.7M. Regarding current trading prices, ADN1.DE is priced at €80.30, while IXX.DE trades at €42.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas IXX.DE's P/E ratio is 28.72. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to IXX.DE's ROE of +0.12%. Regarding short-term risk, ADN1.DE is more volatile compared to IXX.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check IXX.DE's competition here
ADN1.DE vs MCE.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, MCE.DE has a market cap of 232.6M. Regarding current trading prices, ADN1.DE is priced at €80.30, while MCE.DE trades at €14.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas MCE.DE's P/E ratio is -39.17. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to MCE.DE's ROE of -0.10%. Regarding short-term risk, ADN1.DE is more volatile compared to MCE.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check MCE.DE's competition here
ADN1.DE vs A1OS.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, A1OS.DE has a market cap of 231.5M. Regarding current trading prices, ADN1.DE is priced at €80.30, while A1OS.DE trades at €47.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas A1OS.DE's P/E ratio is 14.83. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to A1OS.DE's ROE of +0.14%. Regarding short-term risk, ADN1.DE is more volatile compared to A1OS.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check A1OS.DE's competition here
ADN1.DE vs AEIN.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, AEIN.DE has a market cap of 208.8M. Regarding current trading prices, ADN1.DE is priced at €80.30, while AEIN.DE trades at €18.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas AEIN.DE's P/E ratio is 25.63. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to AEIN.DE's ROE of +0.05%. Regarding short-term risk, ADN1.DE is more volatile compared to AEIN.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check AEIN.DE's competition here
ADN1.DE vs OSP2.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, OSP2.DE has a market cap of 185.2M. Regarding current trading prices, ADN1.DE is priced at €80.30, while OSP2.DE trades at €18.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas OSP2.DE's P/E ratio is 32.95. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to OSP2.DE's ROE of +0.08%. Regarding short-term risk, ADN1.DE is more volatile compared to OSP2.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check OSP2.DE's competition here
ADN1.DE vs 30L3.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, 30L3.DE has a market cap of 134.6M. Regarding current trading prices, ADN1.DE is priced at €80.30, while 30L3.DE trades at €1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas 30L3.DE's P/E ratio is 6.29. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to 30L3.DE's ROE of -0.16%. Regarding short-term risk, ADN1.DE is less volatile compared to 30L3.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ADN1.DE.Check 30L3.DE's competition here
ADN1.DE vs QBY.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, QBY.DE has a market cap of 112.1M. Regarding current trading prices, ADN1.DE is priced at €80.30, while QBY.DE trades at €0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas QBY.DE's P/E ratio is -30.00. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to QBY.DE's ROE of -0.04%. Regarding short-term risk, ADN1.DE is less volatile compared to QBY.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ADN1.DE.Check QBY.DE's competition here
ADN1.DE vs 3IT.F Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, 3IT.F has a market cap of 65.4M. Regarding current trading prices, ADN1.DE is priced at €80.30, while 3IT.F trades at €13.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas 3IT.F's P/E ratio is 19.00. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to 3IT.F's ROE of +0.16%. Regarding short-term risk, ADN1.DE is more volatile compared to 3IT.F. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check 3IT.F's competition here
ADN1.DE vs 3IT.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, 3IT.DE has a market cap of 64.5M. Regarding current trading prices, ADN1.DE is priced at €80.30, while 3IT.DE trades at €13.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas 3IT.DE's P/E ratio is 18.71. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to 3IT.DE's ROE of +0.16%. Regarding short-term risk, ADN1.DE is more volatile compared to 3IT.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check 3IT.DE's competition here
ADN1.DE vs IE2A.F Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, IE2A.F has a market cap of 63.9M. Regarding current trading prices, ADN1.DE is priced at €80.30, while IE2A.F trades at €0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas IE2A.F's P/E ratio is 4.93. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to IE2A.F's ROE of +0.12%. Regarding short-term risk, ADN1.DE is more volatile compared to IE2A.F. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check IE2A.F's competition here
ADN1.DE vs OBS.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, OBS.DE has a market cap of 56.8M. Regarding current trading prices, ADN1.DE is priced at €80.30, while OBS.DE trades at €6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas OBS.DE's P/E ratio is 14.29. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to OBS.DE's ROE of +0.12%. Regarding short-term risk, ADN1.DE is more volatile compared to OBS.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check OBS.DE's competition here
ADN1.DE vs KSC.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, KSC.DE has a market cap of 31M. Regarding current trading prices, ADN1.DE is priced at €80.30, while KSC.DE trades at €0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas KSC.DE's P/E ratio is -1.68. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to KSC.DE's ROE of -0.41%. Regarding short-term risk, ADN1.DE is more volatile compared to KSC.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check KSC.DE's competition here
ADN1.DE vs SYT.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, SYT.DE has a market cap of 30.8M. Regarding current trading prices, ADN1.DE is priced at €80.30, while SYT.DE trades at €3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas SYT.DE's P/E ratio is -9.39. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to SYT.DE's ROE of -0.06%. Regarding short-term risk, ADN1.DE is more volatile compared to SYT.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check SYT.DE's competition here
ADN1.DE vs T3T1.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, T3T1.DE has a market cap of 19.2M. Regarding current trading prices, ADN1.DE is priced at €80.30, while T3T1.DE trades at €5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas T3T1.DE's P/E ratio is 13.78. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to T3T1.DE's ROE of +0.19%. Regarding short-term risk, ADN1.DE is more volatile compared to T3T1.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check T3T1.DE's competition here
ADN1.DE vs PDA.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, PDA.DE has a market cap of 11.8M. Regarding current trading prices, ADN1.DE is priced at €80.30, while PDA.DE trades at €2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas PDA.DE's P/E ratio is 30.50. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to PDA.DE's ROE of +0.35%. Regarding short-term risk, ADN1.DE is less volatile compared to PDA.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ADN1.DE.Check PDA.DE's competition here
ADN1.DE vs AMI.F Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, AMI.F has a market cap of 9.4M. Regarding current trading prices, ADN1.DE is priced at €80.30, while AMI.F trades at €0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas AMI.F's P/E ratio is -2.43. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to AMI.F's ROE of -0.29%. Regarding short-term risk, ADN1.DE is more volatile compared to AMI.F. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check AMI.F's competition here
ADN1.DE vs AMI.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, AMI.DE has a market cap of 9M. Regarding current trading prices, ADN1.DE is priced at €80.30, while AMI.DE trades at €0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas AMI.DE's P/E ratio is -2.33. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to AMI.DE's ROE of -0.29%. Regarding short-term risk, ADN1.DE is more volatile compared to AMI.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check AMI.DE's competition here
ADN1.DE vs SHWK.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, SHWK.DE has a market cap of 7.6M. Regarding current trading prices, ADN1.DE is priced at €80.30, while SHWK.DE trades at €3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas SHWK.DE's P/E ratio is -3.34. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to SHWK.DE's ROE of -0.74%. Regarding short-term risk, ADN1.DE is more volatile compared to SHWK.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check SHWK.DE's competition here
ADN1.DE vs RTC.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, RTC.DE has a market cap of 5.4M. Regarding current trading prices, ADN1.DE is priced at €80.30, while RTC.DE trades at €1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas RTC.DE's P/E ratio is 33.33. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to RTC.DE's ROE of +0.03%. Regarding short-term risk, ADN1.DE is more volatile compared to RTC.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check RTC.DE's competition here
ADN1.DE vs ASKN.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, ASKN.DE has a market cap of 2.4M. Regarding current trading prices, ADN1.DE is priced at €80.30, while ASKN.DE trades at €0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas ASKN.DE's P/E ratio is -0.44. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to ASKN.DE's ROE of +1.04%. Regarding short-term risk, ADN1.DE is less volatile compared to ASKN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ADN1.DE.Check ASKN.DE's competition here
ADN1.DE vs MDV.DU Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, MDV.DU has a market cap of 1.6M. Regarding current trading prices, ADN1.DE is priced at €80.30, while MDV.DU trades at €6.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas MDV.DU's P/E ratio is -71.26. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to MDV.DU's ROE of -0.04%. Regarding short-term risk, ADN1.DE is more volatile compared to MDV.DU. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check MDV.DU's competition here
ADN1.DE vs SFD1.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, SFD1.DE has a market cap of 1.5M. Regarding current trading prices, ADN1.DE is priced at €80.30, while SFD1.DE trades at €0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas SFD1.DE's P/E ratio is -45.00. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to SFD1.DE's ROE of +0.00%. Regarding short-term risk, ADN1.DE is more volatile compared to SFD1.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check SFD1.DE's competition here
ADN1.DE vs EUCA.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, EUCA.DE has a market cap of 990.6K. Regarding current trading prices, ADN1.DE is priced at €80.30, while EUCA.DE trades at €0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas EUCA.DE's P/E ratio is -0.01. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to EUCA.DE's ROE of +2.90%. Regarding short-term risk, ADN1.DE is less volatile compared to EUCA.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ADN1.DE.Check EUCA.DE's competition here
ADN1.DE vs 2QU.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, 2QU.DE has a market cap of 0. Regarding current trading prices, ADN1.DE is priced at €80.30, while 2QU.DE trades at €17.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas 2QU.DE's P/E ratio is N/A. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to 2QU.DE's ROE of -0.11%. Regarding short-term risk, ADN1.DE is more volatile compared to 2QU.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ADN1.DE.Check 2QU.DE's competition here
ADN1.DE vs WDL.DE Comparison August 2025
ADN1.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADN1.DE stands at 515.9M. In comparison, WDL.DE has a market cap of 0. Regarding current trading prices, ADN1.DE is priced at €80.30, while WDL.DE trades at €1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADN1.DE currently has a P/E ratio of -730.00, whereas WDL.DE's P/E ratio is -1.32. In terms of profitability, ADN1.DE's ROE is +0.04%, compared to WDL.DE's ROE of -1.08%. Regarding short-term risk, ADN1.DE is less volatile compared to WDL.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ADN1.DE.Check WDL.DE's competition here